Naglazyme®
2014LS014
Unknown small_molecule terminated
Quick answer
Naglazyme® for Maroteaux-Lamy Syndrome is a Unknown program (small_molecule) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Maroteaux-Lamy Syndrome
- Phase
- Unknown
- Modality
- small_molecule
- Status
- terminated